
Sun Pharma to Consider Raising $1.55B in Debentures
Sun Pharmaceuticals announced plans to consider raising up to 150 billion rupees through non-convertible debentures. The proposal will be evaluated during the upcoming board meeting scheduled for October 12.
Insights:

Sun Pharmaceutical Industries will consider raising up to 150 billion rupees ($1.55 billion) through non-convertible debentures. The board meeting is scheduled for the afternoon of October 12, according to an exchange filing. The financing maneuver marks a major capital-raising effort for India's largest drug maker by market value.








